GlassScriptPhysician profile
Manuel D Gonzalez
NPI 1497740112
$36,892.86
in general payments reported to CMS, 2019-2025
12 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $36K · 2021: $17.32 · 2022: $117 · 2023: $17.59 · 2024: $90.98 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $36,326.07 | 2020 | |
| Novartis Pharmaceuticals Corporation | $145.46 | 2019 | |
| Abbvie INC. | $117.23 | 2022 | |
| Exact Sciences Corporation | $86.38 | 2025 | The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $50.92 | 2024-2025 | Mounjaro, Zepbound |
| Tactile Systems Technology INC | $41.70 | 2025 | Flexitouch Plus, Nimbl |
| Abbott Laboratories | $40.18 | 2023-2024 | Freestyle Libre 3, Freestyle Libre |
| Pfizer INC. | $18.55 | 2024 | |
| Meridian Bioscience INC. | $18.09 | 2024 | |
| Amarin Pharma, INC. | $17.32 | 2021 | |
| Biocompatibles, INC. | $16.96 | 2019 | |
| Amgen INC. | $14.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.